Tarbox Family Office, Inc. Dexcom Inc Transaction History

Tarbox Family Office, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$67.99 - $132.89 $2,515 - $4,916	-37 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$94.08 - $130.2 $2,916 - $4,036	-31 Reduced 45.59%	37 $19,000
Q4 2021 Jan 06, 2022	BUY	$129.87 - $162.82 $1,168 - $1,465	9 Added 15.25%	68 $37,000
Q3 2021 Oct 12, 2021	BUY	$106.71 - $143.18 $1,707 - $2,290	16 Added 37.21%	59 $32,000
Q2 2021 Jul 16, 2021	BUY	$80.99 - $107.93 $809 - $1,079	10 Added 30.3%	43 $18,000
Q1 2021 Apr 27, 2021	BUY	$84.79 - $104.74 $2,119 - $2,618	25 Added 312.5%	33 $12,000
Q4 2020 Jan 27, 2021	SELL	$78.0 - $104.5 $2,496 - $3,344	-32 Reduced 80.0%	8 $3,000
Q3 2020 Oct 22, 2020	BUY	$95.51 - $112.95 $3,438 - $4,066	36 Added 900.0%	40 $16,000
Q1 2020 Apr 30, 2020	BUY	$47.79 - $75.63 $191 - $302	4 New	4 $1,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.